OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ENLV

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Enlivex Therapeutics (ENLV) Earnings Date & Reports

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

ENLV is expected to report earnings to rise 27.77% to -14 cents per share on December 01

Enlivex Therapeutics ENLV Stock Earnings Reports

Q3'25

Est.

$-0.14

Q2'25

Beat

by $0.04

Q1'25

Beat

by $0.01

Q4'24

Missed

by $0.07

Q3'24

Beat

by $0.03

The last earnings report on August 18 showed earnings per share of -11 cents, beating the estimate of -15 cents. With 67.84K shares outstanding, the current market capitalization sits at 24.57M.

View a ticker or compare two or three

Compare

ENLV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ENLV
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ENLV showed earnings on August 18, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

14 Einstein Street

Phone

+972 26208072

Employees

Web

https://www.enlivex.com